1. Legal requirement: Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
Management of serious breaches of clinical trials authorised in the Europe Union (EU)/ European Economic Area (EEA) is defined by Regulation (EU) No 536/2014, which states in Article 52:
“1. The sponsor shall notify the Member States concerned about a serious breach of this Regulation or of the version of the protocol applicable at the time of the breach through the EU portal without undue delay but not later than seven days of becoming aware of that breach.
2. For the purposes of this Article, a ‘serious breach’ means a breach likely to affect to a significant degree the safety and rights of a subject or the reliability and robustness of the data generated in the clinical trial.”
© European Medicines Agency, 2021
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Prochains essais cliniques
-
Peking University Third HospitalPeking University; The First Affiliated Hospital of Anhui Medical University; First Affiliated Hospital, Sun Yat-Sen University et autres collaborateursRecrutementPré-éclampsie | Grossesse à haut risque | Grossesse gémellaire, condition antepartum ou complication | Préterme | Placenta diamniotique dichorionique jumeau | Transfusion de jumeau à jumeau comme condition antepartum | Placenta jumeau | Placenta diamniotique monochorionique jumeauChine
-
Theodor Bilharz Research InstituteRecrutement
-
Sormland County Council, SwedenEskilstuna municipalityPas encore de recrutementLa dépression | Symptômes dépressifs
-
Shandong Suncadia Medicine Co., Ltd.Pas encore de recrutementMaladie rénale diabétique de type 2
-
University of California, San FranciscoPas encore de recrutementMaladies sexuellement transmissibles, bactériennesÉtats-Unis
-
Ayla ErginRecrutement
-
Royal Marsden NHS Foundation TrustPas encore de recrutement
-
Zhejiang UniversityNewislet Biotechnology (Shanghai) Ltd.Recrutement
-
Natera, Inc.Pas encore de recrutement
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; Effik; AUDIPOGPas encore de recrutement
-
M.D. Anderson Cancer CenterPas encore de recrutement
-
Seoul National University HospitalMedtronicRecrutementDiabète de type 1Corée, République de